CSL has announced the sale of its Wuhan Zhong Yuan Rui De Biologicals Products plasma collection and fractionation operations to Chengdu Rongsheng Pharmaceutical for USD$185 million in cash proceeds. …
CSL announces sale of Wuhan plasma collection and fractionation operations
September 5, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Australian company Kazia executes licensing agreement with QIMR Berghofer
September 16, 2024 - - Latest News -
A statement with intent that limits expectations and frames reform as a one-sided trade-off
September 16, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number one of five
September 16, 2024 - - Latest News -
Pharmac announces plan to deploy more of its recent funding boost
September 16, 2024 - - Latest News -
In 236 pages, this one section captures the primary barrier to real reform
September 13, 2024 - - Latest News -
It is never too late for a considered response - caution
September 13, 2024 - - Latest News -
The 'Week in Review' Podcast - 13 September
September 12, 2024 - - Podcast